Search

Your search keyword '"Liu, Kangdong"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Liu, Kangdong" Remove constraint Author: "Liu, Kangdong" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
46 results on '"Liu, Kangdong"'

Search Results

1. Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma

5. Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer

6. NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway

9. Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

11. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

12. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma

14. Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

18. A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC

20. MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma

21. Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A

24. BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression

25. CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway

27. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3

34. A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression

35. SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway

42. Inhibiting breast cancer by targeting the thromboxane A2 pathway

45. MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma

Catalog

Books, media, physical & digital resources